Effects of liraglutide on β-cell-specific glucokinase-deficient neonatal mice

Endocrinology
Jun ShirakawaYasuo Terauchi

Abstract

The glucagon-like peptide-1 receptor agonist liraglutide is used to treat diabetes. A hallmark of liraglutide is the glucose-dependent facilitation of insulin secretion from pancreatic β-cells. In β-cells, the glycolytic enzyme glucokinase plays a pivotal role as a glucose sensor. However, the role of glucokinase in the glucose-dependent action of liraglutide remains unknown. We first examined the effects of liraglutide on glucokinase haploinsufficient (Gck(+/-)) mice. Single administration of liraglutide significantly improved glucose tolerance in Gck(+/-) mice without increase of insulin secretion. We also assessed the effects of liraglutide on the survival rates, metabolic parameters, and histology of liver or pancreas of β-cell-specific glucokinase-deficient (Gck(-/-)) newborn mice. Liraglutide reduced the blood glucose levels in Gck(-/-) neonates but failed to prolong survival, and all the mice died within 1 wk. Furthermore, liraglutide did not improve glucose-induced insulin secretion in isolated islets from Gck(-/-) neonates. Liraglutide initially prevented increases in alanine aminotransferase, free fatty acids, and triglycerides in Gck(-/-) neonates but not at 4 d after birth. Liraglutide transiently prevented liver st...Continue Reading

References

Nov 1, 1993·The Journal of Clinical Investigation·F MatschinskyT L Jetton
Sep 27, 2000·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·B Balkan, X Li
May 15, 2007·Gastroenterology·Laurie L Baggio, Daniel J Drucker
Apr 2, 2009·The Journal of Clinical Endocrinology and Metabolism·Rania Abu-HamdahDariush Elahi
Apr 18, 2009·Nature Reviews. Drug Discovery·Franz M Matschinsky
Aug 19, 2009·Diabetologia·D Russell-JonesUNKNOWN Liraglutide Effect and Action in Diabetes 5 (LEAD-5) met+SU Study Group
Nov 3, 2009·Current Opinion in Endocrinology, Diabetes, and Obesity·Meena Asmar, Jens J Holst
Mar 11, 2010·American Journal of Physiology. Endocrinology and Metabolism·Liu-Luan ZhuYong-Sheng Chang
Mar 13, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Nitika Arora GuptaFrank A Anania
Dec 15, 2010·Journal of Hepatology·Shani Ben-ShlomoSigal Fishman
Jan 18, 2011·Experimental Cell Research·Bo Ahrén

❮ Previous
Next ❯

Citations

Apr 14, 2016·Journal of Diabetes Research·Tuuli SedmanVallo Volke
Sep 12, 2017·International Journal of Environmental Health Research·J YangJ Xu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.